JP5660898B2 - 経口投与用の抗炎症性キナ酸誘導体 - Google Patents

経口投与用の抗炎症性キナ酸誘導体 Download PDF

Info

Publication number
JP5660898B2
JP5660898B2 JP2010533331A JP2010533331A JP5660898B2 JP 5660898 B2 JP5660898 B2 JP 5660898B2 JP 2010533331 A JP2010533331 A JP 2010533331A JP 2010533331 A JP2010533331 A JP 2010533331A JP 5660898 B2 JP5660898 B2 JP 5660898B2
Authority
JP
Japan
Prior art keywords
compound
quinic acid
inflammatory
compounds
scheme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010533331A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011503110A5 (enExample
JP2011503110A (ja
Inventor
チャールズ イエーツ
チャールズ イエーツ
クイ ゼン
クイ ゼン
デュアン ミラー
デュアン ミラー
カーリン トンプスン
カーリン トンプスン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tennessee Research Foundation
Original Assignee
University of Tennessee Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tennessee Research Foundation filed Critical University of Tennessee Research Foundation
Publication of JP2011503110A publication Critical patent/JP2011503110A/ja
Publication of JP2011503110A5 publication Critical patent/JP2011503110A5/ja
Application granted granted Critical
Publication of JP5660898B2 publication Critical patent/JP5660898B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2010533331A 2007-11-09 2008-11-10 経口投与用の抗炎症性キナ酸誘導体 Expired - Fee Related JP5660898B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US261107P 2007-11-09 2007-11-09
US61/002,611 2007-11-09
PCT/US2008/083068 WO2009062200A1 (en) 2007-11-09 2008-11-10 Anti-inflammatory quinic acid derivatives for oral administration

Publications (3)

Publication Number Publication Date
JP2011503110A JP2011503110A (ja) 2011-01-27
JP2011503110A5 JP2011503110A5 (enExample) 2011-10-06
JP5660898B2 true JP5660898B2 (ja) 2015-01-28

Family

ID=40626242

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010533331A Expired - Fee Related JP5660898B2 (ja) 2007-11-09 2008-11-10 経口投与用の抗炎症性キナ酸誘導体

Country Status (6)

Country Link
US (1) US8115031B2 (enExample)
EP (1) EP2219445A4 (enExample)
JP (1) JP5660898B2 (enExample)
AU (1) AU2008323683B2 (enExample)
CA (1) CA2713394C (enExample)
WO (1) WO2009062200A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101284799B (zh) * 2007-03-23 2013-04-03 浙江医药股份有限公司新昌制药厂 咖啡酰奎宁酸含氮衍生物及其制备方法和其药物组合物及用途
WO2010132504A1 (en) 2009-05-11 2010-11-18 University Of Tennessee Research Foundation Anti-inflammatory quinic acid derivatives for radioprotection/radiomitigation
US10369133B2 (en) 2013-07-23 2019-08-06 The University Of Tennessee Research Foundation Immunosuppressive compounds and therapeutics
TWI481600B (zh) * 2013-07-24 2015-04-21 Nat Applied Res Laboratories 一種奎尼酸衍生物、其製程及其用途
US11883457B1 (en) 2022-09-06 2024-01-30 Optigenex Inc. Method of enhancing cognition in individuals with at least normal cognition
CN117547562A (zh) * 2023-05-09 2024-02-13 北京农学院 一种用于抗炎的虎耳草提取物及其制备方法和用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017A (en) * 1849-01-09 Die for bending ttjbe-skelps
US7020A (en) * 1850-01-15 Improvement in harvesting-mac mines
US2918477A (en) * 1954-12-28 1959-12-22 Alberti Carlo Giuseppe Caffeic esters of quinic acid and quinic acid amide and syntheses thereof
US2866734A (en) * 1956-12-05 1958-12-30 Us Vitamin Corp 3-pyridylethyl 2, 4-oxazolidinediones and process
GB1460593A (en) * 1973-06-22 1977-01-06 Ici Ltd Ethanolamine derivatives
US3968211A (en) * 1974-02-11 1976-07-06 The Upjohn Company Compositions and methods of use of amidines for anti-arrhythmic purposes
GB1476351A (en) * 1974-04-17 1977-06-10 Wilkinson Sword Ltd Compounds having a physiological cooling effect and compo sitions containing them
US4582855A (en) * 1981-11-12 1986-04-15 American Hospital Supply Corporation Aromatic and esters of hydroxypropylamines
JPS61251616A (ja) * 1985-04-30 1986-11-08 Agency Of Ind Science & Technol 溶質の放出量の制御方法
HU906340D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Synthesis in solid phase for producing peptonic alcohols
US6964784B2 (en) * 2002-03-07 2005-11-15 Optigenex, Inc. Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
WO2005035534A1 (ja) * 2003-10-08 2005-04-21 Ono Pharmaceutical Co., Ltd. 複素ビシクロ環および複素トリシクロ環化合物およびその医薬
US7482378B2 (en) * 2004-05-28 2009-01-27 Millenium Specialty Chemicals, Inc. Physiological cooling compositions
US8436006B2 (en) * 2004-08-06 2013-05-07 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
WO2007103719A2 (en) * 2006-03-03 2007-09-13 Incyte Corporation MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
CN101400660A (zh) * 2006-03-16 2009-04-01 安斯泰来制药有限公司 三唑衍生物或其盐
CN101284799B (zh) * 2007-03-23 2013-04-03 浙江医药股份有限公司新昌制药厂 咖啡酰奎宁酸含氮衍生物及其制备方法和其药物组合物及用途

Also Published As

Publication number Publication date
EP2219445A4 (en) 2013-05-29
US20090234015A1 (en) 2009-09-17
WO2009062200A1 (en) 2009-05-14
CA2713394A1 (en) 2009-05-14
EP2219445A1 (en) 2010-08-25
AU2008323683A1 (en) 2009-05-14
JP2011503110A (ja) 2011-01-27
US8115031B2 (en) 2012-02-14
AU2008323683B2 (en) 2014-10-02
CA2713394C (en) 2016-01-19

Similar Documents

Publication Publication Date Title
JP5660898B2 (ja) 経口投与用の抗炎症性キナ酸誘導体
JP6182595B2 (ja) Ｓｓａｏの置換３−ハロアリルアミン阻害剤およびその使用
WO2009117987A2 (de) Verwendung von boswelliasäuren und synthetischen boswelliasäurederivaten zur hemmung der mikrosomalen prostaglandin e2 synthase und des cathepsin g
SK284823B6 (sk) Použitie hydroxylamínového derivátu na prípravu farmaceutického alebo kozmetického prostriedku na zvýšenie produkcie molekulových chaperónov, hydroxylamínový derivát a farmaceutické alebo kozmetické prostriedky s jeho obsahom
DE60031705T2 (de) Salicylamid-derivate
JP2021147322A (ja) ステロイド系化合物及びその医薬用途
CN104136436A (zh) 抗纤维化的化合物及其用途
JP2022541780A (ja) Ｎｌｒｐ３インフラマソーム阻害剤としての化合物と組成物とその使用
KR20190077383A (ko) 구강건조증(xerostomia)의 치료를 위한 조성물 및 방법
US6388108B1 (en) Aminosterol compounds and uses thereof
KR20180003530A (ko) 감각 유모 세포 사멸을 예방 또는 치료하기 위한 화합물 및 방법
US8906965B2 (en) Anti-inflammatory quinic acid derivatives for radioprotection/radiomitigation
DE69718469T2 (de) Verbindungen mit wachtumshormon freisetzenden eigenschaften
CN103923158A (zh) A环多氧化取代甘草次酸衍生物及其制备方法和用途
US10787482B2 (en) Epoxyketone compounds for enzyme inhibition
EP3078659B1 (en) 3-furyl-2-cyano-2-acrylamide derivative, preparation method therefor, pharmaceutical composition and use thereof
DE60133273T2 (de) Inhibitoren von peptid deformylase
CN104860847B (zh) 利凡斯的明和咖啡酸、阿魏酸的二聚体,其制备方法及其药物组合物
US8067441B2 (en) Use of collismycin and derivatives thereof as oxidative stress inhibitors
DE69624122T2 (de) Aza-anthracyclinone-derivate
DE69812599T2 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
EP4001263B1 (en) Carbamate-substituted styryl sulfone compound, preparation method, and application thereof
JP2008533122A (ja) 新規なチロシン誘導体
KR101603317B1 (ko) 케르세틴-아미노산 접합체를 포함하는 항암 및 항생제 내성 억제효능을 보이는 조성물 및 그 방법
KR101584528B1 (ko) 케르세틴-아미노산 접합체를 포함하는 항암 및 항생제 내성 억제효능을 보이는 조성물 및 그 방법

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110816

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110816

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130704

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130708

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131004

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131011

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140108

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140813

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140919

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20141015

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141105

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20141202

R150 Certificate of patent or registration of utility model

Ref document number: 5660898

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees